expert reaction to MHRA and NICE news on donanemab for Alzheimer’s disease
Scientists comment on MHRA saying ‘Donanemab licensed for treatment of Alzheimer’s disease in some adults’, and NICE draft guidance saying … read more
Scientists comment on MHRA saying ‘Donanemab licensed for treatment of Alzheimer’s disease in some adults’, and NICE draft guidance saying … read more
Scientists comment on both MHRA and NICE news on lecanemab for Alzheimer’s disease. Fiona Carragher, Chief Policy and Research … read more
With the announcement on 22nd August 2024 from the MHRA and NICE on lecanemab for Alzheimer’s Disease, journalists heard from … read more
A perspective article published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association looks at challenges for new Alzheimer’s drugs. … read more
A conference abstract presented at the Alzheimer’s Association International Conference looks at red meat intake and dementia risk. Dr Richard … read more
Scientists react to findings presented at the Alzheimer’s Association International Conference (AAIC) 2024 about continuous treatment with lecanemab. Prof … read more
A conference abstract at the Alzheimer’s Association International Conference looks at weight loss drug liraglutide and Alzheimer’s disease. Dr … read more
Scientist comment on the EMA decision on the use of lecanemab for Alzheimer’s disease. Prof Robert Howard, Professor of … read more
A study published in Nature Medicine looks at the genetic variants and Alzheimer’s disease. Prof Jonathan Schott, Chief Medical Officer at … read more
A study published in The BMJ looks at antipsychotic use in people with dementia. Dr Richard Oakley, Associate Director of … read more
A study published in Stem Cell Reports looks at a stem cell transplant in mice and transmission of a familial form of … read more
Scientists react to news that the FDA are delaying a decision on the Alzheimer’s drug Donanemab. Prof Robert Howard, … read more
A study published in Nature Aging looks at possible plasma protein biomarkers for dementia risk. Dr Sheona Scales, Director of Research … read more
A study published in Neurology looks at erectile dysfunction drugs and risk of Alzheimer’s Disease. Dr Francesco Tamagnini, Neurophysiologist at the … read more
A study published in Nature Medicine looks at Alzheimer’s Disease in recipients of cadaveric pituitary-derived growth hormone. Dr Richard Oakley, Associate … read more
A study published in JAMA Neurology looks at Tau immunoassays for Alzheimer’s Disease Dr Richard Oakley, Associate Director of Research and … read more
A study published in JAMA Otolaryngology–Head & Neck Surgery looks at hearing loss and hearing aid use and the risk of dementia. … read more
The way dementia is diagnosed has barely changed for nearly two decades, and here’s the shocker: at least a third … read more
A study published in Current Biology looks at navigational mistakes as a possible sign of Alzheimer’s disease. Dr Leah Mursaleen, Head … read more
A study published in Cell Metabolism looks at time-restricted feeding and memory in mouse models of Alzheimer’s disease. Dr … read more